Bullfrog AI Holdings, Inc. (BFRG)
Market Cap | 21.20M |
Revenue (ttm) | 65,000 |
Net Income (ttm) | -5.36M |
Shares Out | 7.85M |
EPS (ttm) | -0.89 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 126,592 |
Open | 3.010 |
Previous Close | 3.020 |
Day's Range | 2.690 - 3.012 |
52-Week Range | 2.360 - 8.590 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | May 22, 2024 |
About BFRG
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obe... [Read more]
Financial Performance
In 2023, BFRG's revenue was $65,000, an increase of 550.00% compared to the previous year's $10,000. Losses were -$5.36 million, 91.1% more than in 2022.
Financial StatementsNews
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
GAITHERSBURG, Md., March 08, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...
BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common Stock
GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial in...
BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip
GAITHERSBURG, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...
WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering
JERSEY CITY, N.J. , Feb. 5, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today BullFrog AI Holdings, Inc. (NASDAQ...
BullFrog AI Announces Closing of $5.7 Million Public Offering
GAITHERSBURG, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial in...
WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering
JERSEY CITY, N.J. , Feb. 1, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that BullFrog AI Holdings, Inc. (N...
Bullfrog AI Announces Pricing of $5.7 Million Public Offering
GAITHERSBURG, Md., Feb. 01, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial in...
BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala
GAITHERSBURG, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...
This AI stock is up 30% on Wednesday: find out more
Bullfrog AI Holdings Inc (NASDAQ: BFRG) says early results of its work with the Lieber Institute for Brain Development have been positive. Its shares are up 35% at writing.
BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data
GAITHERSBURG, Md., Jan. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial i...
BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
GAITHERSBURG, Md., Jan. 16, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...
BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17
GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...
BullFrog AI Issues Letter to Shareholders
GAITHERSBURG, Md., Dec. 29, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...
BullFrog AI Launches Preclinical Study to Investigate BF-114's Potential in Battling Obesity
The market for obesity drugs is projected to exceed $77 billion by 2030 Dr. Randy Seeley, a recognized expert on novel treatments for obesity, to lead study GAITHERSBURG, Md., Dec. 06, 2023 (GLOBE NEW...
ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / October 27, 2023 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG)(NASDAQ:BFRGW) on The RedChip Small...
BullFrog AI to Present at Benzinga All Access Event on October 20
GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...
BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform
Discoveries generated by analyzing The Cancer Genome Atlas using proprietary bfLEAP™ platform Target validation will be conducted through partnership with J. Craig Venter Institute (JCVI), a world-lea...
BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023
GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...
BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform
Purpose-built Data Product Offers Customized Visualization of Relationships and Pathways for Specific Disease Indications Built from High-dimension, Multi-modal Data Sets Purpose-built Data Product Of...
BullFrog AI Founder and CEO Vin Singh to Present Company Overview at Maxim Group's Emerging Growth in AI Virtual Tech Conference Series
GAITHERSBURG, Md., Sept. 14, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...
BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development
The Strategic Collaboration will Leverage BullFrog AI's bfLEAP™ AI Platform to Accelerate R&D Initiatives, Including New Drug Target and Disease Biomarker Identification The Strategic Collaboration wi...
BullFrog AI Announces Investor Webinar with CEO and Founder Vin Singh on Thursday, September 14, 2023
GAITHERSBURG, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...
BullFrog AI Technology Licensed from Johns Hopkins University APL Named Finalist in R&D 100 Awards
Proprietary Machine Learning Technology Powering bfLEAP™ Drug Discovery Platform Among Best in IT/Electrical Category Proprietary Machine Learning Technology Powering bfLEAP™ Drug Discovery Platform A...
RedChip Launches 'Small Stocks, Big Money' Podcast
New podcast series shines a spotlight on undervalued small-cap and microcap stocks ORLANDO, FL / ACCESSWIRE / August 2, 2023 / RedChip Companies, a renowned international investor relations firm speci...
BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
Novel compounds show improved bioavailability relative to mebendazole Novel compounds show improved bioavailability relative to mebendazole